Member Info for draft

sells kept this down

maybe we rise monday then

now can we get Nuvec involved!

KeywordCompanyEPIC/TIDMSEDOL/ISINNews
Search
Print Mail a friend More announcements
Friday 14 August, 2020
Novavax, Inc.
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
UK government to purchase 60 million doses of NVX-CoV2373
Novavax to partner with FUJIFILM Diosynth Biotechnologies to manufacture antigen component of NVX-CoV2373 in the UK
Novavax and UK government to collaborate on Phase 3 clinical trial in UK commencing in the third quarter of this year
Novavax intends to make additional capacity available to global markets
GAITHERSBURG, Md., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has signed a Heads of Terms (Term Sheet) with the Government of the United Kingdom (UK) for the purchase of 60 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine, and a Phase 3 clinical trial to assess the efficacy of the vaccine in the UK population. Novavax will also expand its collaboration with FUJIFILM Diosynth Biotechnologies, which will manufacture the antigen component of NVX-CoV2373 from its Billingham, Stockton-on-Tees site in the UK, in addition to its sites in North Carolina and Texas in the United States. The FUJIFILM Diosynth Biotechnologies site in the UK is expected to produce up to 180 million doses annually, which further boosts the global supply of NVX-CoV2373 for additional markets.

https://www.investegate.co.uk/novavax--inc-/gnw/novavax-and-uk-government-announce-collaboration-and-purchase-agreement-for-novavax--8217--covid-19-vaccine-candidate/20200814060710H7106/

WSG moves up very fast and when u want to buy - you can not buy

not many decent rnss out there today, this getting to 13p to 15p today will not surprise me

Agreement with designer label, Mango, to vend their products.

Financial Highlights:

· Group revenues up 24% to £7.0 million (H1 2019: £5.6 million).

· EBITDA moves from loss to a profit of £0.89 million (H1 2019: loss of £0.05 million).

· Profit before tax of £0.24 million (H1 2019: Loss before tax of £0.79 million).

· Earnings per share 0.16p profit (H1 2019: Loss of 0.58p).

· Operationally cash positive in first half.

· Administration expenses unchanged from H1 2019 at £2.3 million despite additional costs from acquisition of Euro-Ops, new joint ventures and increasing revenue.

· £3m financing facility and £1.75 million equity sharing agreement entered in January 2020.

· Reduced the Group's convertible loan notes by £561,250 to £1,683,750, maturity date for the balance extended to 1 May 2021. As at 30 June 2020 there was £1,590,000 outstanding.

· Increased stockholding by circa £0.4 million to deal with increased sales demands.

· Cash balance of £1.6 million at 30 June 2020 (30 June 2019: £0.3 million).

how many days does it take to carry our repairs?

Looks like a new product similar to Seeing machines launched with a STAR network supplier in South America, Helios compatible all in.

https://www.vtssolution.com/drive-state-monitor-ts-ds02

Learn More
Kylos is a Real time tracking and monitoring solution for the protection and management of any portable asset. It offers an automatic remote track and trace features and continuous control of your assets. Ideal for merchandise, air shipped cargo and assets in remote areas.

Kylos Compact, Kylos Forever, Kylos Forever Air
Kylos_Products.png
Learn More
Our web-based Control Center application is designed for operational security centers. With the Control Center application, you can manage emergency events effitiently. The system allows ease of operation and ensures an immediate response suitable for any type of event.

Control Center
Control_Center.png
Learn More
TS-DS02 is a driver sate intelligence early warning terminal, which based on image recognition technology and inbuilt image intelligent processing core algorithm. TS-DS02 can detect Driver Fatigue, Distraction Warning, Smoking Warning, Calling Warning, Driver abnormal warning.
TS-DS02 is a driver state intelligent early warning terminal, which based on image recognition technology and inbuilt image intelligent processing core algorithm independently developed by our company. On one hand, with special camera, the TS-DS02 can warn the driver once he/she have bad driver behaviors like fatigue, distraction, calling, yawning, smoking and so on. It can also identify the driver ID. On the other hand, it can send data to monitor platform through GPRS/3G/4G device with serial port. It is suitable to safety management for private car, commercial vehicle,
bus, dangerous cargo transport vehicle and so on.
Fleet Management Integration

The TS-DS02 device is integrated with our HELIOS ADVANCED unit for an end-to-end Fleet Management operation

maybve we get an update on the global patents that N$P also applied for

stage 3 is almost done tbh, Evotec will be fast tracking this and then maybe a huge licensing deal

N4 Pharma PLC's shares have hit 16 pence, doubling from 7.95, the previous closing price. The British company reported promising results in its coronavirus research. LON: NAP continues fluctuating at high volatility.

Update: After closing at 12.50 pence in Tuesday's session – off the peak of 16 but more than 50% up on the day – LONG: N4P continues garnering attention and has room to extend its gains on Wednesday. Investors are eager for anything that helps alleviate the immense health and economic pressures caused by COVID-19. That has sent S&P 500 briefly above its record high.

N4P Stock Price: N4 Pharma PLC holds onto high ground amid coronavirus progress, Phase 3 plans
NEWS | 07:03 GMT | By Yohay Elam

https://www.fxstreet.com/news/n4p-stock-price-n4-pharma-plc-nearly-doubles-after-coronavirus-progress-now-moving-to-phase-3-202008121304

Interesting - hes gone and liked a tweet about Atomwises huge raise

Given we are interfacing with Waters UNIFI, we could scupper Atomwise.

I haven't sold even 1 share. Evotec may well use Nuvec to deliver the USA vaccine. Evotecs got the department of defense contract

I recommend surfing the Atomwise website. They have Bayer and Eli lily as clients. This huge raise for them is a game changer. Maybe they make a bid for deepmatter?

Atomwise, a startup using AI to accelerate drug discovery, today secured $123 million in funding. A spokesperson said the funds will enable the startup to scale its technology and team as it expands its portfolio of joint ventures with researchers at the University of Toronto, Duke University School of Medicine, Charles River, Bayer, Eli Lilly, Merck, and others.

Fewer than 12% of all drugs entering clinical trials end up in pharmacies, and it takes at least 10 years for medicines to complete the journey from discovery to the marketplace. Clinical trials alone take six to seven years, on average, putting the cost of R&D at roughly $2.6 billion, according to the Pharmaceutical Research and Manufacturers of America.

Atomwise claims its AtomNet platform can screen 16 billion chemical compounds for potential hits in under two days, expediting a process that would normally take months or years. (Hit identification is often the first step in drug discovery, where the right molecules — hits — that bind to a target protein and modify its function are identified.) AtomNet’s AI algorithms screen for things like potency and the degree to which a drug acts on a given site while guarding against toxicity, and they work on targets in hard-to-reach parts of the body — like the central nervous system — with a hit rate the company claims is 10,000 times better than wet-lab experiments.

In one instance

Raises $123 million.

Very odd. Just get deepmatter to do your work.

induced an expression of the spike protein in the cells.

that's all I ever hear about covid , spike protein, looks like Nuvec can do the business here

I meant Nuvec could get a licensing deal anytime now

given it can do the spiky protein thing and that's been proven

old stagnant holders and some old bored pis, not the time to be selling at all
never could easily get a licensing deal from Evotec and very soon

map is silly low, not many small cap decent Pharma plays left with small market caps.

maybe some bored stagnant placees selling, once they are gone this will motor on

Looks like we open around 14p plus